Angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers vs. calcium channel blockers for 12,478 young hypertensive patients under 40 in 10-year follow-up

被引：0
|
作者：
Jo, S. H. [1 ]
Shim, H. S. [2 ]
Hong, J. Y. [1 ]
Kim, T. H. [2 ]
Cheon, D. Y. [1 ]
Kim, S. A. [1 ]
机构：
[1] Hallym Univ, Sacred Heart Hosp, Anyang, South Korea
[2] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2584
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] COMPARISON OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, CALCIUM ANTAGONISTS AND BETA-BLOCKERS ON ENDOTHELIAL DYSFUNCTION IN HYPERTENSIVE DIABETIC PATIENTS
    Falkovskaya, A. Y.
    Mordovin, V. F.
    Belokopytova, N. V.
    JOURNAL OF HYPERTENSION, 2009, 27 : S238 - S238
  • [42] Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up
    Jeong, Han Saem
    Lim, Hong-Seok
    Park, Hun-Jun
    Lee, Wang-Soo
    Choi, Jin-Oh
    Lee, Hui Seung
    Jo, Sang-Ho
    Hong, Soon Jun
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [43] Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up
    Han Saem Jeong
    Hong‐Seok Lim
    Hun-Jun Park
    Wang-Soo Lee
    Jin-Oh Choi
    Hui Seung Lee
    Sang-Ho Jo
    Soon Jun Hong
    Scientific Reports, 11
  • [44] The use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers may relate to the survival and walking ability in geriatric patients with hip fractures: a 1-year follow-up study
    Qining Chu
    Liqiang Wang
    Qingbo Chu
    BMC Musculoskeletal Disorders, 24
  • [45] The use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers may relate to the survival and walking ability in geriatric patients with hip fractures: a 1-year follow-up study
    Chu, Qining
    Wang, Liqiang
    Chu, Qingbo
    BMC MUSCULOSKELETAL DISORDERS, 2023, 24 (01)
  • [46] COVID-10 clinical outcomes in patients with and without ongoing therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
    Nafakhi, Ahmed
    Rabeea, Ihsan
    AL-Darraji, Rasha
    Nafakhi, Hussein
    Mechi, Ahmed
    ARTERIAL HYPERTENSION, 2022, 26 (01): : 9 - 14
  • [47] Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis - A nationwide cohort study
    Lin, Ting-Tse
    Wu, Cho-Kai
    Liao, Min-Tsun
    Yang, Yao-Hsu
    Chen, Pau-Chung
    Yeih, Dong-Feng
    Lin, Lian-Yu
    PLOS ONE, 2017, 12 (12):
  • [48] Angiotensin converting enzyme inhibitors improve longitudinal myocardial deformation to a greater extent than angiotensin receptor blockers in hypertensives: a 3 year follow-up study
    Ikonomidis, I.
    Trivilou, P.
    Triantafyllidi, H.
    Tzortzis, S.
    Papadopoulos, C.
    Pavlidis, G.
    Paraskevaidis, I.
    Anastasiou-Nana, M.
    Lekakis, J.
    EUROPEAN HEART JOURNAL, 2014, 35 : 378 - 378
  • [49] 10-Year retrospective review of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) toxic doses in children < 6 years old
    Pham, Trang
    Ostrikova, Kim Vo
    Winter, Mark L.
    CLINICAL TOXICOLOGY, 2023, 61 : 167 - 167
  • [50] The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients Is there a room for vitamin D?
    Sukkarieh, Hatouf H.
    Bustami, Rami T.
    Abdu, Manasik N.
    Khokhar, Ayesha A.
    Salih, Amir A.
    Abdalla, Hana K.
    SAUDI MEDICAL JOURNAL, 2020, 41 (10) : 1083 - 1089
12345